Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients

Clinical trial NCT02396316 · COMPLETED

Trial details

NCT number: NCT02396316
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Glaucoma, Neovascular

Start date: 2015-04-02
Primary completion: 2016-06-16
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.